The Zacks Glass Products industry is poised to benefit from the rising demand for glass, both as a packaging option and for use in construction. This is backed by its endless recyclability and sustainability benefits. Growing demand for energy-efficient, smart windows or smart glass panels will be another catalyst for the industry going forward.Companies like O-I Glass, Inc. OI and Apogee Enterprises APOG are expected to gain from efforts to capitalize on this demand by boosting capacity and introducing innovative products to the market.About the IndustryThe Zacks Glass Products industry comprises companies that manufacture and sell glass products. O produces glass containers for packaging beverages, food and pharmaceuticals. Another player in the industry offers coated and high-performance glass used in customized window and wall systems. It caters to the construction industry, ranging from commercial and multi-family residential to institutional buildings. It also provides coated glass for picture framing, wall décor and display applications. Nowadays, companies that make glass for buildings offer smart glass windows using artificial intelligence to adjust and suitably increase access to natural light while minimizing heat and glare. Some have developed electrokinetic technology that can be retrofitted on any glass, enabling buildings to cut energy consumption and save on heating and cooling costs.Major Trends Shaping the Future of the Glass Products IndustryGlass Packaging Gaining Popularity: Glass is increasingly becoming the packaging choice for customers, given its endless recyclability without a loss in quality. More than 80% of recycled bottles are used in making new bottles. This also helps negate the need for raw materials. Every ton of recycled glass saves 1,400 pounds of sand, 430 pounds of soda ash and 400 pounds of limestone/dolomite. As consumers are becoming more aware of their environmental footprint, a sharp spike in demand is noticed for refillable bottles, which offer the most sustainable and economical rigid packaging option. Manufacturers are focusing on improving their products by reducing the weight of the bottles for more convenient handling. Also, premium cosmetic and beverage brands are opting for glass to differentiate their products through packaging and ensure quality maintenance. Demand in the Construction Sector Holds Promise: In recent years, the use of glass gained popularity in construction as a sustainable alternative to traditional building materials, including wood and bricks, owing to its cost-effectiveness, lightweight, immense strength and environmentally friendly factor. Glass increases the influx of natural light in the building, reduces energy consumption, minimizes carbon emissions and enhances the aesthetic appeal of structures. Rising construction activities across the residential, commercial and industrial sectors are likely to fuel the glass products industry’s growth. Increasing investments in the renovation or modernization of the existing infrastructure will also drive the industry’s growth. Various governments are introducing favorable policies and granting incentives to promote green construction to minimize greenhouse emissions and energy consumption, which bodes well for the industry.Technological Innovation is the Key: Some players revolutionized the industry by bringing smart glass panels or smart windows to the market. These innovative products are designed to enable people to lead healthier and more productive lives by increasing access to daylight and views while minimizing glare and heat from the sun and keeping occupants comfortable. These products also help cut down on energy consumption from lighting and HVAC, thus reducing carbon emissions.Pricing, Improving Efficiency to Offset Cost Inflation: The industry is witnessing rising costs for transportation, chemical and fuel, and supply-chain headwinds. Therefore, industry players are increasingly focusing on pricing actions and cost reduction and resorting to automation in manufacturing to boost productivity and efficiency.Zacks Industry Rank Indicates Bright ProspectsThe Zacks Glass Products industry is a two-stock group within the broader Industrial Products sector. The industry currently carries a Zacks Industry Rank #11, which places it in the top 4% of the 246 Zacks industries.The group’s Zacks Industry Rank, basically the average of the Zacks Rank of all the member stocks, indicates bullish prospects in the near term. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.Before we present two Glass Products stocks for investors’ consideration, it is worth looking at the industry’s stock-market performance and its valuation picture.Industry Versus S&P 500 & SectorThe Glass Products industry has underperformed the S&P 500 and the sector in the past year. The stocks in this industry have collectively declined 30.6% against the Industrial Products sector’s gain of 17.5%. The S&P 500 composite has risen 21.7% during the said time frame.One-Year Price Performance Industry's Current ValuationBased on the trailing 12-month EV/EBITDA ratio, a commonly used multiple for valuing Glass Products companies, we see that the industry is currently trading at 4.37X compared with the S&P 500’s 18.32X and the Industrial Products sector’s 20.01X. This is shown in the charts below.Enterprise Value/EBITDA (EV/EBITDA) Ratio (TTM)Enterprise Value/EBITDA (EV/EBITDA) Ratio (TTM)Over the last five years, the industry traded as high as 9.42X and as low as 3.53X, the median being 5.20X.2 Glass Products Stocks to WatchApogee: The company has been benefiting from the strong performance of its Architectural Services segment, which is gaining on improved pricing and product mix, reflecting its strategic shift toward more premium products. The company’s strong project pipeline and recent order trends bode well. Apogee's ongoing efforts to reduce costs and enhance productivity are expected to bolster margins in the coming quarters. Its solid balance sheet provides additional support. Earlier this month, Apogee acquired Kalwall Companies. This deal is expected to solidify APOG’s Architectural Glass segment. Apogee expects this deal to yield $4 million of operational cost synergies by the end of fiscal 2029. Moreover, Kalwall is expected to generate $85 million in revenues within the first 12 months of the deal completion. The company expects an adjusted EBITDA margin of 15%, with a long-term margin target of 20%. The deal is also expected to be accretive to the company’s adjusted earnings in the first year of completion. APOG shares have gained 9.8% in the past three months. The Minneapolis, MN-based entity has a trailing four-quarter earnings surprise of 12.2%, on average. The Zacks Consensus Estimate for earnings for fiscal 2027 has moved up 3% to $2.96 per share over the past 60 days. The company has a long-term earnings growth of 12%. Apogee currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Price & Consensus: APOGO-I Glass: The company continues to invest in joint ventures, incremental capacity, and acquisitions to benefit from the growing demand for glass packaging due to increasing consumer preference for healthy, premium and sustainable products for food and beverage. O-I Glass is currently implementing the first phase of its Fit to Win initiative. This program is expected to reduce redundant production capacity, optimize the network and streamline costs in areas such as selling, general and administrative expenses. The program delivered $300 million of benefits in 2025, higher than the expected $250 million. Year to date, gross savings totaled $115 million or $85 million net savings. OI expects approximately $200 million of Fit to Win benefits in 2026 and at least $650 million over 2024-2027. This is expected to drive higher earnings, enhance economic profit and strengthen free cash flow. Perrysburg, OH-based O-I Glass manufactures and sells glass containers to food and beverage manufacturers, primarily in the Americas, Europe and the Asia Pacific. OI has a long-term estimated earnings growth rate of 7.3%. O-I Glass currently carries a Zacks Rank #3 (Hold). Price & Consensus: OI Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

Why court ruling clears path for Cole Hutson to return to Texas football Austin American-Statesman

In a 2016 UCLA fMRI study, teenagers were more likely to like an Instagram photo with a high, researcher-assigned like count than the same photo with a low count, whether the image was ordinary or risky, showing how little the content itself mattered Silicon Canals

Instagram-Savvy `Cockroaches’ Spur India Pivot in Blow to Modi Bloomberg.com

Tesla recently hosted a specialized showcase at the Tesla Diner, giving media and industry insiders an up-close look at the upcoming Model Y L. The event provided a complete look at the North American long-wheelbase electric SUV, shedding light on several design and functional upgrades. During the hands-on event, journalists got a first look at […] The post Tesla’s New Long-Wheelbase Model Y L Officially Launches in the US appeared first on TeslaNorth.com.

Darwinism emerged powerfully in the 19th century in stark contrast to Lamarckism. According to Popperian epistemology, Darwinism has withstood any attempt at refutation; it has been extensively corroborated. This leads us to affirm that its truth value is almost absolute, even though, according to Popper, we are not in a position to state the absolute truth of any theory; we can only corroborate it to a greater degree, as is the case with Darwinism. At the same time, growing advances in the field of epigenetics suggest that Lamarck was also right by identifying mechanisms that allow the transgenerational transmission of phenotypic traits induced by the environment. This retrospectively validates the Lamarckian premise of the inheritance of acquired characters, calling into question the exclusivity of random genetic mutation as the sole evolutionary driver within neo-Darwinism. When contemporary evolutionary theory attempts to absorb these environmental modifications , it often introduces intermediate auxiliary hypotheses. My question is about epistemology: Does the use of auxiliary hypotheses, to integrate epigenetic inheritance into neo-Darwinism, constitute a legitimate defense mechanism, or does it represent a symptom of theoretical degeneration?

Facebook groups and a rumour of an open border drive the Ceuta crossing Brussels Signal

HEALTH & POWER Health & Power will help you visualize your resources in the style of an Action Role-Playing Game (ARPG). This plugin is...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Innodata Inc (INOD). This company, which is in the Zacks Engineering - R and D Services industry, shows potential for another earnings beat.When looking at the last two reports, this company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 121.06%, on average, in the last two quarters.For the last reported quarter, Innodata Inc came out with earnings of $0.42 per share versus the Zacks Consensus Estimate of $0.13 per share, representing a surprise of 223.08%. For the previous quarter, the company was expected to post earnings of $0.21 per share and it actually produced earnings of $0.25 per share, delivering a surprise of 19.05%.Price and EPS SurpriseFor Innodata Inc, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.Innodata Inc currently has an Earnings ESP of +17.65%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #1 (Strong Buy) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on August 6, 2026.With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

https://www.cnbc.com/2026/07/29/yes-network-msg-networks-dazn-streaming.html

A Ventura County man was arrested for allegedly attacking his elderly stepfather with a butcher knife. The Ventura County Sheriff’s Office identified the suspect as Chad Nelson, 40, of Oak Park. On July 30, deputies were called to an assault at a home on the 5900 block of East Sunny Vista Avenue in Oak Park [...]

A Los Angeles-based OnlyFans model and social media influencer is due in court Friday, accused of stealing from wealthy men she met on dating apps, after she was re-arrested this week in a separate luxury goods theft case connected to the 2025 Coachella Music Festival. Adva Lavie, 29, who also goes by Mia Ventura, was [...]

OnPage Recognized in the Gartner® Hype Cycle™ for ITSM, 2026 EIN Presswire

DexCom, Inc. DXCM reported second-quarter 2026 adjusted earnings per share (EPS) of 70 cents, which beat the Zacks Consensus Estimate of 61 cents by 14.8%. The company reported adjusted EPS of 48 cents per share in the prior-year quarter.Revenues increased 13.1% year over year to $1.31 billion and surpassed the consensus mark of $1.30 billion by 1.01%.DXCM registered GAAP net income per share of 64 cents, up from the year-ago quarter’s figure of 45 cents.Following better-than-expected results and raised guidance, shares of DXCM have risen 8.3% in today’s pre-market trading. The stock has gained 12.3% in the year-to-date period against an 11.7% decline in the industry. The broader S&P 500 Index increased 6.6% in the same period.Image Source: Zacks Investment ResearchDXCM's U.S. Business Delivers Solid GrowthU.S. revenues totaled $933.4 million, up 11% from the year-ago quarter. Growth was supported by strong new-patient additions, share capture and a sequential increase in new customer starts.Management noted that demand remained broad-based across patient categories. Dexcom also highlighted a substantial untapped opportunity, with roughly 9 million people in the United States already covered for continuous glucose monitoring but not yet using the technology.Dexcom's International Revenues Outpace U.S. GrowthInternational revenues increased 19% year over year to $375 million. On an organic basis, international sales advanced 16%, benefiting from reimbursement expansion and stronger adoption in markets such as France and Canada.The company also broadened its overseas product portfolio with the launch of Dexcom Flex in Germany. The 15-day sensor targets basal-insulin users and people with type 2 diabetes not using insulin in selected markets.Margin Analysis of DXCMAdjusted gross profit totaled $838.5 million, up 20.6% from the prior-year quarter’s level. DexCom reported an adjusted gross margin (as a percentage of revenues) of 64.1%, up 400 basis points year over year.Research and development expenses totaled $153 million, up 3.2% year over year. Selling, general and administrative expenses totaled $358.7 million, up 9.4% from the year-ago quarter.The company reported adjusted operating income of $328.3 million, up 48% from the prior-year period’s level. Adjusted operating margin (as a percentage of revenues) was 25.1%, up 590 basis points year over year.Financial Position of DexcomDXCM exited the second quarter with cash, cash equivalents and marketable securities worth $1.95 billion compared with $2.42 billion in the first quarter of 2026.Cumulative cash provided by operating activities at the end of the second quarter of 2026 was $794.8 million compared with $486.8 million a year ago.The company repurchased approximately $600 million of shares during the quarter under its $1 billion 2026 authorization and completed the acquisition of Nutrisense.DexCom, Inc. Price, Consensus and EPS Surprise DexCom, Inc. price-consensus-eps-surprise-chart | DexCom, Inc. QuoteDXCM Raises 2026 Revenue and Margin OutlookDXCM now expects 2026 revenues of $5.18-$5.25 billion compared with the previous range of $5.16-$5.25 billion. The updated guidance implies annual growth of 11-13% and reflects stronger organic growth expectations, partly offset by an anticipated $15 million foreign-exchange headwind in the second half.The company raised its adjusted gross margin forecast to approximately 64% from 63-64%. It also increased adjusted operating margin guidance to 23.5-24% from 23-23.5% and adjusted EBITDA margin guidance to 31.5-32% from 31-31.5%.Wrapping UpDexCom exited the second quarter of 2026 on a strong note, supported by solid revenue growth, continued margin expansion and sustained momentum across its CGM portfolio. The company advanced the rollout of the G7 15 Day system, which is now available to all adult G7 customers in the United States following integration for Tandem pump users, including Mobi. DexCom expects to convert nearly half of its U.S. customer base to the extended-wear system by the end of 2026.The company also achieved an important international milestone as Health Canada cleared G7 15 Day, marking the product’s first regulatory approval outside the United States. DexCom plans to launch the system in Canada during the second half of 2026 and expand it into additional international markets over time, supporting broader access and adoption.DexCom further strengthened its clinical positioning through the CONNECT randomized trial for people with type 2 diabetes not using insulin. Participants using DexCom CGM achieved a 1.6-percentage-point A1C improvement, spent more than five additional hours per day in the target glucose range and recorded median device usage of 97% over 26 weeks. Looking ahead, the company remains focused on expanding access, advancing product innovation and sustaining long-term growth across global CGM markets.DXCM’s Zacks Rank & Other Stocks to ConsiderDXCM currently carries a Zacks Rank #2 (Buy).Some other top-ranked stocks in the broader medical space are McKesson MCK, Phibro Animal Health PAHC andCardinal Health CAH.McKesson carries a Zacks Rank #2 at present and has an estimated long-term growth rate of 13.7%. MCK’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 3.09%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.McKesson’s shares have gained 8.8% against the industry’s 12.7% decline in the year-to-date period.Phibro Animal Health, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 21.5%. PAHC’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 16.25%.Phibro Animal Health stock has climbed 44.2% against the industry’s 17.1% decline in the year-to-date period.Cardinal Health, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 17%. CAH’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 10.27%.Cardinal Health’s shares have lost 2.6% compared with the industry’s 3.1% decline in the year-to-date period. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

🚨 The teenager was rushed to hospital facebook.com

Constellium SE CSTM and Ryerson Holding Corporation RYZ are leading players in the aluminum industry, supported by global operations and diversified business portfolios. With aluminum prices remaining elevated amid global economic uncertainty and persistent trade tensions, comparing these companies can help investors identify opportunities within the Zacks Metal Products - Distribution industry.Aluminum has become an attractive investment due to growing demand from electric vehicles, increased use of recycled aluminum and advancements in rechargeable batteries. Its demand is also rising as industries focus more on sustainability and efficiency. In addition, the recovery in global air travel has led aircraft manufacturers to increase production, driving higher demand for aluminum used in aircraft parts such as fuselages and wings.But which of these two stocks is better positioned to capitalize on these trends? Let’s compare their fundamentals to find out.The Case for ConstelliumConstellium’s Packaging & Automotive Rolled Products segment remains a key growth driver. In the second quarter of 2026, the segment’s revenues increased 36% year over year to $1.7 billion, driven by higher metal prices. It also benefited from supply shortages of automotive rolled products in North America, which supported the overall performance.Also, strength in the Aerospace & Transportation segment is aiding CSTM. The segment’s shipments increased 21% to 65 thousand metric tons in the second quarter of 2026, driven by higher shipments of aerospace and transportation, industry and defense (TID) rolled products. Revenues from the segment increased 38% to $680 million, supported by strong shipments and higher metal prices.The company’s Automotive Structures & Industry segment’s revenues grew 9% year over year to $458 million in the second quarter of 2026, supported by higher metal prices. Stable shipments compared with the prior-year quarter also supported the segment’s performance.CSTM also remains committed to rewarding its shareholders handsomely through share buybacks. For instance, it generated a solid free cash flow of $95 million in the first six months of 2026 and returned approximately $48 million to shareholders through share repurchases. It’s worth noting that in March 2026, the company’s board authorized a new share repurchase program of up to $300 million. The program became effective on May 21, 2026, and will remain in effect till Dec. 31, 2028.However, Constellium has been witnessing the impacts of escalating costs and expenses over time. In the second quarter of 2026, the cost of sales increased 23.3% year over year. Selling and administrative expenses also rose 14.8% in the quarter. The increase in operating expenses, if not controlled, might adversely impact the company’s margins in the quarters ahead.The Case for RyersonRyerson benefits from a diversified business structure that helps offset weakness in one end market with strength in others. The company is well-positioned to benefit from rising infrastructure spending, reshoring trends, increased fabrication outsourcing and ongoing manufacturing supply-chain restructuring. Also, its investments in expanding its non-ferrous polishing, buffing and grinding capabilities are expected to bolster the company's long-term position in the market.A key growth driver for Ryerson remains its aluminum product line. Aluminum prices and Midwest premiums increased during the second quarter of 2026, primarily due to supply disruptions in the Middle East. RYZ’s Aluminum shipments increased 10% year over year to 55,000 tons during the quarter. Revenues from the product line surged 41.8% to $434 million, aided by higher metal prices.In the same period, shipments from both the carbon steel and stainless steel product lines increased 67% and 45%, year over year, respectively. Also, revenues from these product lines grew 89.3% and 63.8%, respectively, due to an increase in average selling prices.In the second quarter, Ryerson’s total revenues increased 71.6% year over year to $2 billion, while total shipments rose 60.5% to 804,000 tons. For the third quarter of 2026, the company expects net sales of $1.87-$1.95 billion. Average selling prices are expected to remain flat or increase up to 2%.However, the company’s warehousing, delivery, selling, general and administrative expenses increased 58.7% year over year to $320.3 million in the second quarter. The increase mainly reflected the addition of Olympic Steel’s operating expenses and higher costs associated with the expanded revenue and shipment base.Also, high debt levels remain a concern for Ryerson. It exited the second quarter of 2026 with total debt of $955 million and net debt of $913 million, up $47 million and $30 million, respectively, from the first quarter of 2026. The increase reflected higher working capital requirements associated with increased revenues.How Does the Zacks Consensus Estimate Compare for CSTM & RYZ?The Zacks Consensus Estimate for CSTM’s 2026 sales and earnings per share (EPS) implies year-over-year growth of 30.6% and 84.9%, respectively. The company’s EPS estimates for 2026 have increased 6.3% over the past 30 days.Image Source: Zacks Investment ResearchWhile the consensus estimate for RYZ’s 2026 sales implies year-over-year growth of 53.9%, the same for EPS indicates an increase of 170.5%. The company’s EPS estimates remained steady over the past 30 days for 2026.Image Source: Zacks Investment ResearchPrice Performance and Valuation of CSTM & RYZIn the past six months, Constellium’s shares have surged 20.5%, while Ryerson stock has declined 8.6%.Image Source: Zacks Investment ResearchConstellium is trading at a forward 12-month price-to-earnings ratio of 9.42X compared with its median of 9.99X over the last five years. Ryerson is trading at a forward 12-month price-to-earnings ratio of 15.68X, above its median of 10.44X over the last five years.Image Source: Zacks Investment ResearchFinal TakeConstellium continues to witness strength across its key business segments, supported by favorable aluminum pricing. Also, its commitment to returning capital to shareholders augurs well for its long-term growth prospects. However, rising operating costs remain a concern for its margins.In contrast, Ryerson is benefiting from its diversified business model, robust momentum in its aluminum product portfolio and improving demand across steel categories, supported by higher metal prices. The company is well-positioned for continued growth, driven by healthy shipment volumes. However, increasing expenses and elevated debt levels continue to pose risks to its financial performance.Given these factors, CSTM seems a better pick for investors than RYZ currently. While Constellium carries a Zacks Rank #3 (Hold), RYZ currently has a Zacks Rank #5 (Strong Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

Texas baseball pitcher Sam Cozart recovering from foot surgery ahead of sophomore season Austin American-Statesman

What is McDowell's response, or would be his response, to Davidson's challenge put forth in his paper, Action, Reason, and Causes for ant-causalist in action explanation? Is McDowell an anti-causalist?